Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes
Identifieur interne : 006C38 ( Main/Merge ); précédent : 006C37; suivant : 006C39Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes
Auteurs : Wendy A. Shultis [États-Unis] ; E. Jennifer Weil [États-Unis] ; Helen C. Looker [États-Unis] ; Jeffrey M. Curtis [États-Unis] ; Marc Shlossman [États-Unis] ; Robert J. Genco [États-Unis] ; William C. Knowler [États-Unis] ; Robert G. Nelson [États-Unis]Source :
- Diabetes care [ 0149-5992 ] ; 2007.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Abstract
OBJECTIVE - The purpose of this study was to investigate the effect of periodontitis on development of overt nephropathy, defined as macroalbuminuria, and end-stage renal disease (ESRD) in type 2 diabetes. RESEARCH DESIGN AND METHODS - Individuals residing in the Gila River Indian Community aged ≥25 years with type 2 diabetes, one or more periodontal examination, estimated glomerular filtration rate ≥60 ml/min per 1.73 m2, and no macroalbuminuria (urinary albumin-to-creatinine ratio ≥300 mg/g) were identified. Periodontitis was classified as none/ mild, moderate, severe, or edentulous using number of teeth and alveolar bone score. Subjects were followed to development of macroalbuminuria or ESRD, defined as onset of renal replacement therapy or death attributed to diabetic nephropathy. RESULTS - Of the 529 individuals, 107 (20%) had none/mild periodontitis, 200 (38%) had moderate periodontitis, 117 (22%) had severe periodontitis, and 105 (20%) were edentulous at baseline. During follow-up of up to 22 years, 193 individuals developed macroalbuminuria and 68 developed ESRD. Age- and sex-adjusted incidence of macroalbuminuria and ESRD increased with severity of periodontitis. After adjustment for age, sex, diabetes duration, BMI, and smoking in a proportional hazards model, the incidences of macroalbuminuria were 2.0, 2.1, and 2.6 times as high in individuals with moderate or severe periodontitis or those who were edentulous, respectively, compared with those with none/mild periodontitis (P =0.01). Incidences of ESRD in individuals with moderate or severe periodontitis or in those who were edentulous were 2.3, 3.5, and 4.9 times as high, respectively, compared with those with none/mild periodontitis (P = 0.02). CONCLUSIONS - Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes. Whether treatment of periodontitis will reduce the risk of diabetic kidney disease remains to be determined.
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000437
- to stream PascalFrancis, to step Curation: 000266
- to stream PascalFrancis, to step Checkpoint: 000419
Links to Exploration step
Pascal:07-0230055Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes</title>
<author><name sortKey="Shultis, Wendy A" sort="Shultis, Wendy A" uniqKey="Shultis W" first="Wendy A." last="Shultis">Wendy A. Shultis</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Weil, E Jennifer" sort="Weil, E Jennifer" uniqKey="Weil E" first="E. Jennifer" last="Weil">E. Jennifer Weil</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Looker, Helen C" sort="Looker, Helen C" uniqKey="Looker H" first="Helen C." last="Looker">Helen C. Looker</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Curtis, Jeffrey M" sort="Curtis, Jeffrey M" uniqKey="Curtis J" first="Jeffrey M." last="Curtis">Jeffrey M. Curtis</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shlossman, Marc" sort="Shlossman, Marc" uniqKey="Shlossman M" first="Marc" last="Shlossman">Marc Shlossman</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Department of Oral Biology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Arizona School of Dentistry and Oral Health</s1>
<s2>Mesa, Arizona</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Genco, Robert J" sort="Genco, Robert J" uniqKey="Genco R" first="Robert J." last="Genco">Robert J. Genco</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Department of Oral Biology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Knowler, William C" sort="Knowler, William C" uniqKey="Knowler W" first="William C." last="Knowler">William C. Knowler</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nelson, Robert G" sort="Nelson, Robert G" uniqKey="Nelson R" first="Robert G." last="Nelson">Robert G. Nelson</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0230055</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0230055 INIST</idno>
<idno type="RBID">Pascal:07-0230055</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000437</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000266</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000419</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000419</idno>
<idno type="wicri:doubleKey">0149-5992:2007:Shultis W:effect:of:periodontitis</idno>
<idno type="wicri:Area/Main/Merge">006C38</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes</title>
<author><name sortKey="Shultis, Wendy A" sort="Shultis, Wendy A" uniqKey="Shultis W" first="Wendy A." last="Shultis">Wendy A. Shultis</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Weil, E Jennifer" sort="Weil, E Jennifer" uniqKey="Weil E" first="E. Jennifer" last="Weil">E. Jennifer Weil</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Looker, Helen C" sort="Looker, Helen C" uniqKey="Looker H" first="Helen C." last="Looker">Helen C. Looker</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Curtis, Jeffrey M" sort="Curtis, Jeffrey M" uniqKey="Curtis J" first="Jeffrey M." last="Curtis">Jeffrey M. Curtis</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shlossman, Marc" sort="Shlossman, Marc" uniqKey="Shlossman M" first="Marc" last="Shlossman">Marc Shlossman</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Department of Oral Biology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Arizona School of Dentistry and Oral Health</s1>
<s2>Mesa, Arizona</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Genco, Robert J" sort="Genco, Robert J" uniqKey="Genco R" first="Robert J." last="Genco">Robert J. Genco</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Department of Oral Biology, State University of New York at Buffalo</s1>
<s2>Buffalo, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Knowler, William C" sort="Knowler, William C" uniqKey="Knowler W" first="William C." last="Knowler">William C. Knowler</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nelson, Robert G" sort="Nelson, Robert G" uniqKey="Nelson R" first="Robert G." last="Nelson">Robert G. Nelson</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health</s1>
<s2>Phoenix, Arizona</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Diabetes care</title>
<title level="j" type="abbreviated">Diabetes care</title>
<idno type="ISSN">0149-5992</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Diabetes care</title>
<title level="j" type="abbreviated">Diabetes care</title>
<idno type="ISSN">0149-5992</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Human</term>
<term>Nephropathy</term>
<term>Periodontitis</term>
<term>Renal failure</term>
<term>Type 2 diabetes</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parodontite</term>
<term>Homme</term>
<term>Néphropathie</term>
<term>Insuffisance rénale</term>
<term>Diabète type 2</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">OBJECTIVE - The purpose of this study was to investigate the effect of periodontitis on development of overt nephropathy, defined as macroalbuminuria, and end-stage renal disease (ESRD) in type 2 diabetes. RESEARCH DESIGN AND METHODS - Individuals residing in the Gila River Indian Community aged ≥25 years with type 2 diabetes, one or more periodontal examination, estimated glomerular filtration rate ≥60 ml/min per 1.73 m<sup>2</sup>
, and no macroalbuminuria (urinary albumin-to-creatinine ratio ≥300 mg/g) were identified. Periodontitis was classified as none/ mild, moderate, severe, or edentulous using number of teeth and alveolar bone score. Subjects were followed to development of macroalbuminuria or ESRD, defined as onset of renal replacement therapy or death attributed to diabetic nephropathy. RESULTS - Of the 529 individuals, 107 (20%) had none/mild periodontitis, 200 (38%) had moderate periodontitis, 117 (22%) had severe periodontitis, and 105 (20%) were edentulous at baseline. During follow-up of up to 22 years, 193 individuals developed macroalbuminuria and 68 developed ESRD. Age- and sex-adjusted incidence of macroalbuminuria and ESRD increased with severity of periodontitis. After adjustment for age, sex, diabetes duration, BMI, and smoking in a proportional hazards model, the incidences of macroalbuminuria were 2.0, 2.1, and 2.6 times as high in individuals with moderate or severe periodontitis or those who were edentulous, respectively, compared with those with none/mild periodontitis (P =0.01). Incidences of ESRD in individuals with moderate or severe periodontitis or in those who were edentulous were 2.3, 3.5, and 4.9 times as high, respectively, compared with those with none/mild periodontitis (P = 0.02). CONCLUSIONS - Periodontitis predicts development of overt nephropathy and ESRD in individuals with type 2 diabetes. Whether treatment of periodontitis will reduce the risk of diabetic kidney disease remains to be determined.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Arizona</li>
<li>État de New York</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Arizona"><name sortKey="Shultis, Wendy A" sort="Shultis, Wendy A" uniqKey="Shultis W" first="Wendy A." last="Shultis">Wendy A. Shultis</name>
</region>
<name sortKey="Curtis, Jeffrey M" sort="Curtis, Jeffrey M" uniqKey="Curtis J" first="Jeffrey M." last="Curtis">Jeffrey M. Curtis</name>
<name sortKey="Genco, Robert J" sort="Genco, Robert J" uniqKey="Genco R" first="Robert J." last="Genco">Robert J. Genco</name>
<name sortKey="Knowler, William C" sort="Knowler, William C" uniqKey="Knowler W" first="William C." last="Knowler">William C. Knowler</name>
<name sortKey="Looker, Helen C" sort="Looker, Helen C" uniqKey="Looker H" first="Helen C." last="Looker">Helen C. Looker</name>
<name sortKey="Nelson, Robert G" sort="Nelson, Robert G" uniqKey="Nelson R" first="Robert G." last="Nelson">Robert G. Nelson</name>
<name sortKey="Shlossman, Marc" sort="Shlossman, Marc" uniqKey="Shlossman M" first="Marc" last="Shlossman">Marc Shlossman</name>
<name sortKey="Shlossman, Marc" sort="Shlossman, Marc" uniqKey="Shlossman M" first="Marc" last="Shlossman">Marc Shlossman</name>
<name sortKey="Weil, E Jennifer" sort="Weil, E Jennifer" uniqKey="Weil E" first="E. Jennifer" last="Weil">E. Jennifer Weil</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006C38 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 006C38 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Main |étape= Merge |type= RBID |clé= Pascal:07-0230055 |texte= Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes }}
![]() | This area was generated with Dilib version V0.6.32. | ![]() |